“Midlife is a critical window for both men and women where we can really set up the brain to be more resilient or more vulnerable to dementia in later life,” said study senior author Kaitlin Casaletto as researchers at the University of California, Santa Barbara, the University of California, San Francisco, and international institutions published findings showing that menopause triggers measurable molecular shifts in the blood linked to brain aging and Alzheimer’s disease risk.
Blood molecules change across reproductive stages
Using advanced proteomic technologies, researchers examined thousands of proteins across pre-, peri-, and postmenopausal women from the Jacobs Lab’s Healthy Aging Study. The team identified a set of 16 circulating blood molecules that change across reproductive stages, including proteins involved in inflammatory and neuronal processes alongside molecules associated with Alzheimer’s disease. According to Neuroscience News, these shifts tracked directly to changing levels of estradiol and follicle-stimulating hormone using STRAW+10 staging criteria, rather than chronological age alone. Declines in estradiol correlated with elevations in systemic inflammatory proteins, while parallel spikes in follicle-stimulating hormone accompanied proteins tied directly to amyloid- and tau-related Alzheimer’s biology. These molecular patterns were successfully replicated in a dataset of more than 2,800 women from the UK Biobank, confirming that menopause is tied to accelerated aging markers across multiple organ systems.
Long-Term Cognitive Outcomes in Older Women
To evaluate whether midlife molecular changes carry neurological consequences decades later, investigators analyzed archival data from four independent cohorts encompassing nearly 12,000 older women in their 60s and 70s. Women who harbored higher levels of these risk proteins demonstrated poorer memory and thinking abilities. In the largest cohort, this specific molecular signature was associated with a 15% increased risk of developing Alzheimer’s dementia over the subsequent 16 years. The study also established a direct connection to clinical menopause symptoms, noting that women reporting severe night sweats exhibited the sharpest elevations in inflammatory proteins.
Researcher Perspectives and Caveats
Study authors emphasize that the biological transition does not mean menopause directly causes dementia. “Most women do not develop Alzheimer’s, and the clinical significance of individual Alzheimer’s-related protein changes detected during midlife remains uncertain,” Casaletto explained, while pointing out that the research highlights midlife as an opportunity to study brain aging and identify factors promoting risk and resilience. Emily Jacobs, a professor of psychological and brain sciences at UCSB, noted that women spend roughly one-third of their lives after the menopause transition, yet researchers know remarkably little about the biology connecting menopause to later-life brain health. The ultimate goal of the research team is to develop a blood test acting as an early-warning sign of dementia risk, functioning similarly to cholesterol tests used to gauge heart disease risk.
Future Longitudinal Menopause Project
Determining how changes in hormones, proteins, symptoms, and brain health unfold together requires longitudinal studies following the same women across the menopause transition. To address this need, the UCSB team is launching the Longitudinal Menopause Project in collaboration with scientists nationwide, and researchers are actively recruiting participants. The study was led by Madeline Wood Alexander at the Sunnybrook Research Institute in Canada alongside Rowan Saloner and Kaitlin Casaletto at UCSF, with additional collaborators from Stanford University, the University of Toronto, and other institutions. Financial support was provided in part by the Ann S. Bowers Women’s Brain Health Initiative, Wellcome Leap, the National Institutes of Health, and the Noyce Trust.
Frequently Asked Questions
What specific criteria were used to stage menopause in the study?
Researchers staged participants using the STRAW+10 (Stages of Reproductive Aging Workshop + 10) criteria to evaluate the years-long endocrine flux rather than treating menopause as a binary event defined solely by the final menstrual period.
How many proteins were initially analyzed in the blood samples?
Investigators used multiplex assays measuring more than 100 blood-borne proteins known to reflect neurodegenerative, inflammatory, and neurovascular processes before identifying the 16 core molecules that showed coordinated shifts across reproductive stages.
Which institutions and funding bodies supported the research?
The work was led by researchers at UC Santa Barbara, UC San Francisco, and the Sunnybrook Research Institute, with support from the Ann S. Bowers Women’s Brain Health Initiative, Wellcome Leap, the National Institutes of Health, and the Noyce Trust.
What biological samples were collected from the UCSB cohort participants?
Participants fasted for eight hours before a morning venous blood draw, allowing researchers to analyze serum for gonadotropin and sex steroid hormones including follicle-stimulating hormone, 17β-estradiol, progesterone, sex hormone-binding globulin, dehydroepiandrosterone sulfate, and testosterone.
- Merthyr woman’s delayed breast cancer diagnosis due to dismissed lumps
- Mental health worker details household finances
- Biological Aging: How Chronic Stress Accelerates the Aging Process (archynewsy.com)
- Tulane University Study Finds Cannabis Use Linked to Higher Cardiovascular Disease Risk (archyworldys.com)